Lockheed Martin Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Lockheed Martin Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-96,700	Closed	-$6.16M	–	130
2017 Q3	$6.16M	Buy	96,700 +68,500	+243%	+$4M	0.33%	39
2017 Q2	$1.57M	Buy	+28,200	New	+$1.53M	0.09%	96
2016 Q3	–	Sell	-12,000	Closed	-$883K	–	122
2016 Q2	$883K	Hold	12,000	–	–	0.09%	92
2016 Q1	$767K	Hold	12,000	–	–	0.07%	65
2015 Q4	$825K	Hold	12,000	–	–	0.08%	65
2015 Q3	$710K	Hold	12,000	–	–	0.08%	75
2015 Q2	$798K	Buy	+12,000	New	+$791K	0.04%	104

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lockheed Martin Investment Management's BMY Position: Q4 2017 in Review

Lockheed Martin Investment Management sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 96,700 shares — an estimated $6.16M sold.

Lockheed Martin Investment Management first reported a position in BMY in Q2 2015 and held it in 7 quarters. The position peaked at $6.16M in Q3 2017. 1,735 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

Lockheed Martin Investment Management reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
Lockheed Martin Investment Management sold 96,700 Bristol-Myers Squibb shares in Q4 2017, an estimated $6.16M.
Lockheed Martin Investment Management first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 7 quarters.
Lockheed Martin Investment Management's Bristol-Myers Squibb position peaked at $6.16M in Q3 2017.
1,735 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Lockheed Martin Investment Management's 13F filing for Q4 2017, filed 18 Jan 2018.